Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
722
-
Total 13F shares, excl. options
-
67.6M
-
Shares change
-
-511K
-
Total reported value, excl. options
-
$20.2B
-
Value change
-
-$216M
-
Put/Call ratio
-
1.66
-
Number of buys
-
339
-
Number of sells
-
-365
-
Price
-
$300.16
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q3 2024
848 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q3 2024.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 722 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.6M shares
of 71.9M outstanding shares and own 94% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.99M shares), BlackRock, Inc. (7.28M shares), Bank of New York Mellon Corp (3.25M shares), STATE STREET CORP (3.21M shares), Artisan Partners Limited Partnership (3.07M shares), ALLIANCEBERNSTEIN L.P. (2.6M shares), APG Asset Management N.V. (2.31M shares), BROWN ADVISORY INC (2.29M shares), FRANKLIN RESOURCES INC (2.28M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.74M shares).
This table shows the top 722 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.